Altered small-world properties of gray matter networks in breast cancer

BackgroundBreast cancer survivors, particularly those treated with chemotherapy, are at significantly increased risk for long-term cognitive and neurobiologic impairments. These deficits tend to involve skills that are subserved by distributed brain networks. Additionally, neuroimaging studies have shown a diffuse pattern of brain structure changes in chemotherapy-treated breast cancer survivors that might impact large-scale brain networks.MethodsWe therefore applied graph theoretical analysis to compare the gray matter structural networks of female breast cancer survivors with a history of chemotherapy treatment and healthy age and education matched female controls.ResultsResults revealed reduced clustering coefficient and small-world index in the brain network of the breast cancer patients across a range of network densities. In addition, the network of the breast cancer group had less highly interactive nodes and reduced degree/centrality in the frontotemporal regions compared to controls, which may help explain the common impairments of memory and executive functioning among these patients.ConclusionsThese results suggest that breast cancer and chemotherapy may decrease regional connectivity as well as global network organization and integration, reducing efficiency of the network. To our knowledge, this is the first report of altered large-scale brain networks associated with breast cancer and chemotherapy.

[1]  Neda Bernasconi,et al.  Graph-theoretical analysis reveals disrupted small-world organization of cortical thickness correlation networks in temporal lobe epilepsy. , 2011, Cerebral cortex.

[2]  S. Shen-Orr,et al.  Networks Network Motifs : Simple Building Blocks of Complex , 2002 .

[3]  Michael R Hamblin,et al.  CA : A Cancer Journal for Clinicians , 2011 .

[4]  P. Ganz,et al.  Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen , 2004, Journal of clinical and experimental neuropsychology.

[5]  Danielle Smith Bassett,et al.  Small-World Brain Networks , 2006, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[6]  Dinggang Shen,et al.  Brain anatomical networks in early human brain development , 2011, NeuroImage.

[7]  Andrew J Saykin,et al.  Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Yutaka Matsuoka,et al.  Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy , 2007, Cancer.

[9]  Edward T. Bullmore,et al.  Whole-brain anatomical networks: Does the choice of nodes matter? , 2010, NeuroImage.

[10]  Ruth O'Hara,et al.  Prefrontal cortex and executive function impairments in primary breast cancer. , 2011, Archives of neurology.

[11]  Alan C. Evans,et al.  Small-world anatomical networks in the human brain revealed by cortical thickness from MRI. , 2007, Cerebral cortex.

[12]  Daniel L. Rubin,et al.  Network Analysis of Intrinsic Functional Brain Connectivity in Alzheimer's Disease , 2008, PLoS Comput. Biol..

[13]  Olaf Sporns,et al.  THE HUMAN CONNECTOME: A COMPLEX NETWORK , 2011, Schizophrenia Research.

[14]  Alan C. Evans,et al.  Structural Insights into Aberrant Topological Patterns of Large-Scale Cortical Networks in Alzheimer's Disease , 2008, The Journal of Neuroscience.

[15]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[16]  B. Miller,et al.  Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.

[17]  Amir Poreh,et al.  The Quantified Process Approach to Neuropsychological Assessment , 2006 .

[18]  K. Sneppen,et al.  Specificity and Stability in Topology of Protein Networks , 2002, Science.

[19]  Andrew J. Saykin,et al.  Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study , 2010, Breast Cancer Research and Treatment.

[20]  C. M. Coppens,et al.  Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats , 2009, Behavioural Brain Research.

[21]  Hiroto Kuwabara,et al.  Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging. , 2008, Clinical breast cancer.

[22]  S. Kesler,et al.  Regional Brain Activation during Verbal Declarative Memory in Metastatic Breast Cancer , 2009, Clinical Cancer Research.

[23]  C. Blomqvist,et al.  Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  B. Pedersen,et al.  Low-dose endotoxemia and human neuropsychological functions , 2005, Brain, Behavior, and Immunity.

[25]  Hiroshi Fukuda,et al.  Age‐related changes in topological organization of structural brain networks in healthy individuals , 2012, Human brain mapping.

[26]  G. Winocur,et al.  The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice , 2006, Pharmacology Biochemistry and Behavior.

[27]  S. Mohile,et al.  An update on cancer- and chemotherapy-related cognitive dysfunction: current status. , 2011, Seminars in oncology.

[28]  Andrew J. Saykin,et al.  Candidate mechanisms for chemotherapy-induced cognitive changes , 2007, Nature Reviews Cancer.

[29]  E. Bullmore,et al.  Hierarchical Organization of Human Cortical Networks in Health and Schizophrenia , 2008, The Journal of Neuroscience.

[30]  A. Dale,et al.  Focal thinning of the cerebral cortex in multiple sclerosis. , 2003, Brain : a journal of neurology.

[31]  Andreas Daffertshofer,et al.  Comparing Brain Networks of Different Size and Connectivity Density Using Graph Theory , 2010, PloS one.

[32]  D. Simard,et al.  Fastest learning in small-world neural networks , 2004, physics/0402076.

[33]  Deborah A. Lowe,et al.  Estimating Premorbid Intelligence among Older Adults: The Utility of the AMNART , 2011, Journal of aging research.

[34]  S. Shen-Orr,et al.  Network motifs: simple building blocks of complex networks. , 2002, Science.

[35]  William J Jagust,et al.  Estrogen- and tamoxifen-associated effects on brain structure and function , 2004, NeuroImage.

[36]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[37]  Joaquín Goñi,et al.  Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway. , 2009, Archives of neurology.

[38]  Scott Holland,et al.  Template-O-Matic: A toolbox for creating customized pediatric templates , 2008, NeuroImage.

[39]  R. A. Samatovicz,et al.  Genetics and brain injury: apolipoprotein E. , 2000, The Journal of head trauma rehabilitation.

[40]  Matti Laine,et al.  Frontal and Temporal Dopamine Release during Working Memory and Attention Tasks in Healthy Humans: a Positron Emission Tomography Study Using the High-Affinity Dopamine D2 Receptor Ligand [11C]FLB 457 , 2005, The Journal of Neuroscience.

[41]  Brianne A. Kent,et al.  The impact of age-related ovarian hormone loss on cognitive and neural function. , 2012, Current topics in behavioral neurosciences.

[42]  M. Dodd,et al.  A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients , 2011, Supportive Care in Cancer.

[43]  Michael E. Phelps,et al.  Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy , 2007, Breast Cancer Research and Treatment.

[44]  Alexander Leemans,et al.  Chemotherapy‐induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients , 2011, Human brain mapping.

[45]  O. Sporns,et al.  Organization, development and function of complex brain networks , 2004, Trends in Cognitive Sciences.

[46]  B. Collins.  Acute and Late Onset Cognitive Dysfunction Associated With Chemotherapy in Women With Breast Cancer: Wefel JS, Saleeba AK, Buzdar AU, et al (The Univ of Texas M D Anderson Cancer Ctr, Houston) Cancer 116:3348-3356, 2010 , 2011 .

[47]  J. Vardy.  Cognitive function in breast cancer survivors. , 2009, Cancer treatment and research.

[48]  D. Veltman,et al.  Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer , 2011, Human brain mapping.

[49]  Alan C. Evans,et al.  Revealing modular architecture of human brain structural networks by using cortical thickness from MRI. , 2008, Cerebral cortex.

[50]  Jeffrey R Petrella,et al.  Use of graph theory to evaluate brain networks: a clinical tool for a small world? , 2011, Radiology.

[51]  Mark Noble,et al.  Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system , 2008, Journal of biology.

[52]  M. Muller,et al.  Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. , 2006, Journal of the National Cancer Institute.

[53]  C. Meyers,et al.  Neuropsychological Sequelae of Non-Central Nervous System Cancer and Cancer Therapy , 2008, Neuropsychology Review.

[54]  J. Savard,et al.  Cognitive impairments associated with breast cancer treatments: results from a longitudinal study , 2009, Breast Cancer Research and Treatment.

[55]  H. Cohen,et al.  Cytokines and Cognition—The Case for A Head‐to‐Toe Inflammatory Paradigm , 2002, Journal of the American Geriatrics Society.

[56]  Olaf Sporns,et al.  Complex network measures of brain connectivity: Uses and interpretations , 2010, NeuroImage.

[57]  J. Bakkum-Gamez,et al.  Challenges in the gynecologic care of premenopausal women with breast cancer. , 2011, Mayo Clinic proceedings.

[58]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[59]  K. Worsley,et al.  Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load. , 2009, Brain : a journal of neurology.

[60]  K. Hermelink.  Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer , 2011, Cancer.

[61]  R. Tsien,et al.  Specificity and Stability in Topology of Protein Networks , 2022 .

[62]  Michael Petrides,et al.  The Neural Circuitry of Executive Functions in Healthy Subjects and Parkinson's Disease , 2010, Neuropsychopharmacology.

[63]  Mark Noble,et al.  CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo , 2006, Journal of biology.

[64]  A. Saykin,et al.  The relationship of APOE genotype to neuropsychological performance in long‐term cancer survivors treated with standard dose chemotherapy , 2003, Psycho-oncology.

[65]  J. Koolhaas,et al.  Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat , 2008, Behavioural Brain Research.